- Home
- VISN vs CORT Comparison
VISN vs CORT Comparison
Compare VISN & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VISN | CORT |
|---|---|---|
| Founded | 1976 | 1998 |
| Country | United States | United States |
| Employees | 4500 | N/A |
| Industry | Radio And Television Broadcasting And Communications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.0B | 3.7B |
| IPO Year | N/A | 2001 |
Fundamental Metrics
Financial Performance| Metric | VISN | CORT |
|---|---|---|
| Price | $11.67 | $52.08 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 5 |
| Target Price | $21.00 | ★ $96.50 |
| AVG Volume (30 Days) | ★ 8.0M | 979.9K |
| Earning Date | 04-30-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $761,407,000.00 |
| Revenue This Year | $9.44 | $26.08 |
| Revenue Next Year | $5.91 | $26.98 |
| P/E Ratio | $5.37 | ★ N/A |
| Revenue Growth | N/A | ★ 12.79 |
| 52 Week Low | $9.47 | $28.66 |
| 52 Week High | $19.91 | $91.00 |
Technical Indicators
Market Signals| Indicator | VISN | CORT |
|---|---|---|
| Relative Strength Index (RSI) | 30.22 | 72.68 |
| Support Level | $9.47 | $32.95 |
| Resistance Level | $19.28 | $90.00 |
| Average True Range (ATR) | 0.58 | 2.09 |
| MACD | -0.47 | 0.31 |
| Stochastic Oscillator | 21.95 | 88.33 |
Price Performance
Historical ComparisonAbout VISN Vistance Networks Inc. Common Stock
Vistance Networks Inc operates in the communications technology sector, providing solutions designed to support the delivery and management of communications services. It serves customers globally through teams involved in product development, implementation, and customer support. The company designs and develops network infrastructure and connectivity solutions focused on reliability and performance. Its offerings include intelligent networking technologies intended to support evolving communication requirements.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.